MIND: Artemis in the Removal of Intracerebral Hemorrhage

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.

Also called NCT03342664

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 236 participants (enrolled count) (from the registry)
Sponsor
  • Penumbra Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03342664
Other papers using this trial's data
  • Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage: The MIND Randomized Clinical Trial JAMA neurology, 2025-11-01 DOI, PubMed 40892424, PMC12406146 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Canada, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03342664. Randomized; single masking; primary purpose treatment. Start 2018-02-06 (actual); primary completion 2024-02-20 (actual). Results posted on 2026-01-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MIND: Artemis in the Removal of Intracerebral Hemorrhage
Condition
Cerebral Hemorrhage
Condition
Brain Hemorrhage
Condition
Cerebral Parenchymal Hemorrhage
Condition
Intracerebral Hemorrhage
Intervention (Device)
Artemis + Medical Management
Intervention (Other)
Best Medical Management Alone (MM)
Lead sponsor
Penumbra Inc. (class: industry)

Record details

Record id
cardio:ct-nct03342664
Content hash
c799dbd5fe1f847af16fa7908ab8a8dafe8fce9d8b682353e4ed4ae6ec699939